Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acalypha australis L. extract is a **plant-derived extract** prepared from *Acalypha australis* and investigated in preclinical studies as a potential therapeutic or functional-food ingredient. Public literature describes mainly **aqueous or water-soluble extracts** that showed anti-obesity activity in high-fat-diet mouse and 3T3-L1 adipocyte models, where the extract reduced lipid accumulation and adipocyte differentiation, with reported downregulation of **PPARγ** and **C/EBPα** expression. Separate mouse studies in ulcerative colitis reported anti-inflammatory effects associated with reduced inflammatory cytokine release and inhibition of **NF-κB** pathway signaling. This is not an approved pharmaceutical with a defined single active moiety; rather, it is a heterogeneous botanical extract with mechanism inferred from preclinical pharmacology rather than a validated molecular target profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acalypha australis l. extract.